Navigation Links
Battelle Selects Xie to Develop Biomarker Services
Date:6/25/2008

COLUMBUS, Ohio, June 25 /PRNewswire-USNewswire/ -- Battelle is strengthening its customer-focused biomarker services portfolio to pharmaceutical, biotechnology, medical device, and government clients, and Kevin Xie will lead those efforts as Battelle's Vice President of Biomarker Services.

Battelle offers a suite of biomarker services, including biomarker discovery, qualification, and validation services to help our clients better define molecular mechanisms of diseases, toxicity, and therapeutic responses.

Xie brings an impressive background to Battelle. He has expertise in pharmaceutical, medical device and diagnostics spanning a number of therapeutic areas including oncology, immunology and infectious diseases.

He has been the director and head of global business development of specialty pharmaceuticals at Boehringer Ingelheim Corp. for the last two years. For four years prior to that, Xie was the director and head of global business development for diabetes care for Bayer Healthcare. At Vertex Pharmaceuticals from 2000-02, he was the director of licensing and business development. For the three years prior to that, Xie was the director of business development and strategic planning at Baxter Healthcare.

Xie earned a Ph.D. in molecular biology at Yale University as well as an MBA in finance and strategy. He earned bachelor's and master's degrees from Fudan University in Shanghai, China.

"We are pleased to hire Kevin not only because we believe he is a quality person but because his diverse background made him the perfect candidate for the job," said Barbara Kunz, President of Battelle's Health and Life Sciences Global Business. "The mix of business, biology, and pharmacological work in his career will make him successful here."

Battelle's Global Health and Life Sciences Global Business delivers a comprehensive set of R&D services to solve complex challenges for government health agencies and medical device, biotech
'/>"/>

SOURCE Battelle
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Ventaira Pharmaceuticals Announces Acquisition of Assets by Battelle
2. MEDRAD, Battelle Win Medical Design Excellence Award for MEDRAD XDS(TM) Extravasation Detector
3. Battelle Collaborating With Korean Partners to Advance Energy Efficiency and Health and Life Sciences Initiatives in Korea
4. Battelle Earns 2008 Presidential Green Chemistry Award
5. MedAssets Supply Chain Systems Selects Siemens Medical Solutions Diagnostics for Chemistry, Automation and Immunoassay Solutions
6. Detroit Department of Health and Wellness Promotion Selects Netsmart Technologies Public Health Software
7. E-Rad Solutions Selects Compressus Enterprise Systems Integration Technology to Fuel Entry Into Teleradiology Market
8. Rosetta Genomics Selects PCR as Platform for its microRNA-based Diagnostics to be Launched in 2008, Licensed Nanogens MGB Probe Technology
9. GeneSeek Selects the British Midlands as Base for New UK/European Operations
10. AmSurg Selects SciQuest Eprocurement Solution to Automate Purchasing of Medical Goods and Services
11. GSA Selects Cascades Technologies, Inc. (CTi) to Support USA.gov
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... Caustic soda is utilized in the production of zeolites, sodium ... lead in the global caustic soda market, followed by the ... in the USA, Germany, Brazil and Canada, is currently the ... of output and production capacities. , The global caustic soda ... year in the years ahead. The APAC region is the ...
(Date:10/31/2014)... Lawrence, MA (PRWEB) October 30, 2014 ... from Latin America were hosted by Charm Sciences ... October. During their week in the US, the ... chemical residue control, hygiene management, and process verification, ... state-of-the-art facility. , This was the first visit ...
(Date:10/31/2014)... (PRWEB) October 31, 2014 Following the ... a free learning webinar to introduce its new product ... directors and biostatisticians. , Launched in September, Formedix On ... suite of clinical trial automation tools. For the first ... web browser. And by introducing Formations – a revolutionary ...
(Date:10/31/2014)... The report "Dairy Alternative (Beverage) ... Flavored, Sweetened, Unsweetened), Channel (Supermarket, Health Store, Pharmacy, ... Forecast to 2018," defines and segments the dairy ... of revenue and volume for plant-based dairy alternative ... reach $14 Billion by 2018 with the Asia-Pacific ...
Breaking Biology Technology:China to Dominate Caustic Soda Market Through 2018, Says Merchant Research & Consulting in Its New Study 2Charm Sciences Hosts Executives from Latin America for Dairy Safety Executive Seminar 2Formedix to Introduce "Revolutionary" Clinical Trial Automation Software with Learning Webinar 2Dairy Alternative Beverage Market Projected to Reach $14 Billion by 2018 - Report by MarketsandMarkets 2Dairy Alternative Beverage Market Projected to Reach $14 Billion by 2018 - Report by MarketsandMarkets 3Dairy Alternative Beverage Market Projected to Reach $14 Billion by 2018 - Report by MarketsandMarkets 4
... are pleased to release the third in a ... , This third Podcast titled "Commercialization ... crucial issues around how nanotechnology can be taken ... commercial outcomes. , Dr Peter Binks, CEO of ...
... 7 Dendreon Corporation (Nasdaq:,DNDN) today announced that ... position of senior vice president of clinical affairs ... with over a decade of oncology,drug development and ... was instrumental to the filing of the company,s ...
... in the Department of Physics & Engineering ... with colleagues from the University of California, ... authored the article, High-frequency single-photon source with ... December 2007 issue of Nature Photonics ( ...
Cached Biology Technology:Commercialization of nanotechnology 2Dendreon Promotes Dr. Mark Frohlich to Senior Vice President of Clinical Affairs and Chief Medical Officer 2Dendreon Promotes Dr. Mark Frohlich to Senior Vice President of Clinical Affairs and Chief Medical Officer 3Professor Strauf's research is Nature Photonics’ cover article 2
(Date:10/31/2014)... developed a new test that can distinguish between birds ... avian influenza virus or "bird flu" with those that ... step in the fight against this often fatal strain ... populations of South East Asia, particularly Indonesia and Vietnam. ... transmission to humans and the threat of a pandemic ...
(Date:10/31/2014)... 30, 2014  HITLAB SM , a healthcare ... its inaugural HITLAB Innovators Summit SM on ... HITLAB will partner with the Clinton Foundation,s Health ... ProtoHack, Columbia Business School Alumni Club of ... Engineering and Operations Research, bringing together leaders in ...
(Date:10/30/2014)... has received a $1.04 million grant from the ... and reduce osteoarthritis using a patient,s own stem ... of biodegradable polymers., Liping Tang, a bioengineering professor ... the research is primarily focused on helping soldiers ... found that if we inject microscaffolding that we,ve ...
Breaking Biology News(10 mins):New step towards eradication of H5N1 bird flu 2HITLAB Announces Inaugural HITLAB Innovators Summit 2HITLAB Announces Inaugural HITLAB Innovators Summit 3UTA researcher uses microscaffolding injections to mend cartilage, prevent osteoarthritis 2
... like cancer typically destroy nasty malignant cells, while ... in synthetic biology, researchers are designing molecules intelligent ... cells alone. "We basically design molecules that actually ... of the cellular state before delivering the therapeutic ...
... 1996 marked the beginning of a revolution in biological and ... by now the number of characterised species is approaching 1000, ... a few years away mapping the genetic evolution of ... able to identify the genetic causes of human disease and ...
... , A mutual epidemiological relationship between aggressive periodontitis and ... at the universities of Kiel, Dresden, Amsterdam and Bonn have ... on chromosome 9, which maps to a genetic region that ... latest edition of the specialist journal PLoS Genetics . ...
Cached Biology News:Engineers create intelligent molecules that seek-and-destroy diseased cells 2Engineers create intelligent molecules that seek-and-destroy diseased cells 3Genetic differences between yeasts greater than those between humans and chimpanzees 2
... Ambion's custom siRNA service provides the premium ... silencing research. Custom siRNAs can be readily ... base target sequence, or by providing the ... out Ambion's Silencer Validated and Silencer Pre-designed ...
, Premium quality synthesis and purification , You provide the sequence, we'll do the rest , Rigorous quality control , Your choice of purification method, amount and format , Available annealed...
, Premium quality synthesis and purification , You provide the sequence, we'll do the rest , Rigorous quality control , Your choice of purification method, amount and format , Available annealed...
Human TGF-beta RIIb Affinity Purified Polyclonal Ab...
Biology Products: